Physician

Daniel Yugi Patten, MD

According to 2025 Medicare claims, Daniel Patten, MD (NPI: 1245490390) practices family practice in the Logan, UT-ID market, with the plurality of this provider's patient population coming from Franklin, ID. This provider's primary affiliated billing organization is FRANKLIN COUNTY MEDICAL CENTER (NPI: 1548355811; TIN: 826003449) and primary practice location at 83263-1326. Patten is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Patten's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 15 traditional Medicare patients, billed 46 HCPCS/CPT codes, and received $2,844 in Medicare payments. 2024 Part D data shows 2,886 prescription claims across 170 beneficiaries totaling $273,875 in drug costs, led by Mounjaro (Tirzepatide). 2024 DME data shows 140 claims. Open Payments data shows 21 records totaling $355. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $14,153 to $2,844. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $150,683 and ending at $273,875. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $62,831 to $9,684.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	128	1,425	$14,153
2016	29	81	$4,685
2017	23	52	$3,231
2018	26	49	$3,465
2019	25	57	$4,239
2020	19	71	$4,436
2021	13	48	$3,331
2022	19	59	$3,093
2023	15	46	$2,844
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	171	2,594	$150,683
2016	192	3,365	$179,440
2017	163	2,927	$214,813
2018	158	2,465	$117,663
2019	158	2,226	$122,477
2020	168	2,580	$133,679
2021	188	2,645	$145,961
2022	192	2,523	$147,559
2023	189	2,778	$232,254
2024	170	2,886	$273,875

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	253	$45,781
2016	N/R	199	$24,651
2017	12	212	$24,354
2018	11	143	$8,467
2019	15	184	$10,924
2020	13	231	$15,774
2021	N/R	219	$16,312
2022	N/R	157	$10,884
2023	N/R	143	$9,233
2024	N/R	140	$6,788

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	42	1,176	$43,879
Jardiance	Empagliflozin	55	1,960	$37,969
Ozempic	Semaglutide	28	980	$31,588
Eliquis	Apixaban	56	1,480	$29,400
Farxiga	Dapagliflozin Propanediol	41	1,086	$21,354

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	30	$2,174
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	15	$1,046
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	11	$988
E0443	Portable oxygen contents, gaseous, 1 month's supply = 1 unit	N	N/R	18	$744
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	15	$718

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$355	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Yugi Patten, MD?

Tedicare shows public-source Medicare data for Daniel Yugi Patten, MD (NPI 1245490390), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Yugi Patten, MD have ACO affiliation data?

Daniel Yugi Patten, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Daniel Yugi Patten, MD?

Daniel Yugi Patten, MD is linked to FRANKLIN COUNTY MEDICAL CENTER (billing NPI 1548355811) in the available physician profile data.

Does Daniel Yugi Patten, MD have Open Payments data?

Daniel Yugi Patten, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.